| Literature DB >> 16018700 |
Mark S Jensen1, R Scott Hoerrner, Wenjie Li, Dorian P Nelson, Gary J Javadi, Peter G Dormer, Dongwei Cai, Robert D Larsen.
Abstract
A practical synthesis of 2-[3-(4-fluoro-3-pyridin-3-yl-phenyl)-imidazo[1,2-a]pyrimidin-7-yl]-propan-2-ol (1), an oral GABA(A) alpha(2/3)-selective agonist, is described. The five-step process, which afforded 1 in 40% overall yield, included imidazopyrimidine 2 and pyridine boronic acid 4 as key fragments. The synthesis is highlighted by consecutive Pd-catalyzed coupling steps to assemble the final free base 1 in high yield and regioselectivity. A novel method for Pd removal in the final step is also described.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16018700 DOI: 10.1021/jo050741o
Source DB: PubMed Journal: J Org Chem ISSN: 0022-3263 Impact factor: 4.354